Risk factors

Design Therapeutics (DSGN) risk factors

Item 1A of every Design Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open DSGN in Gloom →
Design Therapeutics' chart, financials and news, free in your browser.Open DSGN in Gloom →
  • FY2025 10-K risk factors
    92 risks8 new3 dropped18 reworded

    New trade tariff risks were added alongside expanded discussions on healthcare legislation like the OBBBA and the ACA.

    Filed Mar 09, 2026
  • FY2024 10-K risk factors
    87 risks

    Design Therapeutics faces heavy reliance on its novel GeneTAC platform, unproven clinical candidates like DT-216, and ongoing capital needs.

    Filed Mar 10, 2025